{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:40:17Z","timestamp":1791290417677,"version":"4.3.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0380"],"award-info":[{"award-number":["W81XWH-21-1-0380"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["P30CA043703"],"award-info":[{"award-number":["P30CA043703"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 NS127824"],"award-info":[{"award-number":["R01 NS127824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 NS124594"],"award-info":[{"award-number":["R01 NS124594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30CA043703"],"award-info":[{"award-number":["P30CA043703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.trecan.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:29:15Z","timestamp":1741458555000},"page":"560-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Protease regulation of tumor-immune cell symbiosis"],"prefix":"10.1016","volume":"11","author":[{"given":"Lizhi","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Huang-Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9328","authenticated-orcid":false,"given":"Peiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2025.02.004_bb0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.tcb.2021.06.008","article-title":"Circadian regulation of cancer cell and tumor microenvironment crosstalk","volume":"31","author":"Xuan","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2021.02.004","article-title":"Context-dependent glioblastoma-macrophage\/microglia symbiosis and associated mechanisms","volume":"42","author":"Xuan","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molmed.2024.02.004","article-title":"Epigenetic regulation of tumor-immune symbiosis in glioma","volume":"30","author":"Liu","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.trecan.2025.02.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178540","article-title":"Epigenetic regulation of tumor immunity","volume":"134","author":"Pang","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0025","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1038\/s41388-022-02406-7","article-title":"Co-dependencies in the tumor immune microenvironment","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.02.004_bb0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2022.04.010","article-title":"Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma","volume":"8","author":"Pang","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2025.02.004_bb0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tips.2022.04.002","article-title":"Pharmacological targeting of the tumor\u2013immune symbiosis in glioblastoma","volume":"43","author":"Pang","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.trecan.2025.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","article-title":"Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression","volume":"15","author":"Khan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/2326-6066.CIR-21-0559","article-title":"Circadian regulator CLOCK drives immunosuppression in glioblastoma","volume":"10","author":"Xuan","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2025.02.004_bb0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41556-020-0491-2","article-title":"Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis","volume":"22","author":"Nishida","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0055","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41590-023-01605-y","article-title":"Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma","volume":"24","author":"Pang","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0060","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","article-title":"Obesity induces PD-1 on macrophages to suppress anti-tumour immunity","volume":"630","author":"Bader","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0070","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","article-title":"Immunotherapy for glioblastoma: current state, challenges, and future perspectives","volume":"21","author":"Liu","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0075","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the interface of the co-evolving cancer ecosystem","volume":"186","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0080","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41592-020-0891-z","article-title":"On the cutting edge: protease-based methods for sensing and controlling cell biology","volume":"17","author":"Chung","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2025.02.004_bb0085","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41467-023-37227-z","article-title":"Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0090","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s12276-023-00975-5","article-title":"TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.trecan.2025.02.004_bb0095","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1200\/JCO.2004.08.054","article-title":"Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196","volume":"22","author":"Sparano","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc2228","article-title":"Emerging roles of proteases in tumour suppression","volume":"7","author":"L\u00f3pez-Ot\u00edn","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.02.004_bb0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0110","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/s41467-023-38605-3","article-title":"ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0115","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma","volume":"4","author":"Pang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.trecan.2025.02.004_bb0120","article-title":"Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer","volume":"134","author":"Li","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0125","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cell.2022.03.041","article-title":"Enhanced safety and efficacy of protease-regulated CAR-T cell receptors","volume":"185","author":"Labanieh","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41590-020-0641-5","article-title":"Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling","volume":"21","author":"Han","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0135","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","article-title":"Tumor-reactive antibodies evolve from non-binding and autoreactive precursors","volume":"185","author":"Mazor","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0140","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","article-title":"Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis","volume":"15","author":"Liao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0145","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1038\/s41467-022-34087-x","article-title":"Divergent regulation of basement membrane trafficking by human macrophages and cancer cells","volume":"13","author":"Bahr","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0150","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1158\/0008-5472.CAN-05-3592","article-title":"Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor \u03b2 correlates with the survival of breast cancer patients","volume":"66","author":"Savinov","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.02.004_bb0155","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","article-title":"Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0160","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3390\/cancers12092579","article-title":"Cathepsin inhibition modulates metabolism and polarization of tumor-associated macrophages","volume":"12","author":"Oelschlaegel","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.trecan.2025.02.004_bb0165","article-title":"AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments","volume":"134","author":"Zhang","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0170","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","article-title":"PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis","volume":"22","author":"Hou","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113560","article-title":"Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18","volume":"42","author":"Miyauchi","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.02.004_bb0180","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1038\/s41467-018-06178-1","article-title":"USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and \u03b2-TrCP and promotes cancer malignancy","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0185","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1038\/s41467-021-25032-5","article-title":"USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.trecan.2025.02.004_bb0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0200","doi-asserted-by":"crossref","first-page":"16000","DOI":"10.1073\/pnas.1507294112","article-title":"Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1","volume":"112","author":"El Rayes","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2025.02.004_bb0205","doi-asserted-by":"crossref","first-page":"50447","DOI":"10.18632\/oncotarget.14579","article-title":"Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7","volume":"8","author":"Vachharajani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2025.02.004_bb0210","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.cell.2021.04.016","article-title":"Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0215","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neo.2014.08.013","article-title":"Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment","volume":"16","author":"Deryugina","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.trecan.2025.02.004_bb0220","doi-asserted-by":"crossref","first-page":"20262","DOI":"10.1073\/pnas.0706438104","article-title":"Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis","volume":"104","author":"Ardi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2025.02.004_bb0225","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/cancers12020505","article-title":"Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian cancer","volume":"12","author":"Muqaku","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.trecan.2025.02.004_bb0230","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41565-021-00988-z","article-title":"A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours","volume":"16","author":"Cui","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0235","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1038\/s41467-022-31250-2","article-title":"Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-\u03b2 type II receptor signaling","volume":"13","author":"Xie","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155224","article-title":"SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells","volume":"132","author":"Wu","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0255","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/imm.13552","article-title":"USP12 positively regulates M-MDSC function to inhibit antitumour immunity through deubiquitinating and stabilizing p65","volume":"167","author":"Zhan","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.trecan.2025.02.004_bb0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-022-35348-5","article-title":"Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis","volume":"14","author":"Arimoto","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0265","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1158\/2326-6066.CIR-20-0492","article-title":"Pro- and antitumorigenic capacity of immunoproteasomes in shaping the tumor microenvironment","volume":"9","author":"Leister","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2025.02.004_bb0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/85321","article-title":"Costimulation of CD8\u03b1\u03b2 T cells by NKG2D via engagement by MIC induced on virus-infected cells","volume":"2","author":"Groh","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0275","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell\u2013driven tumor immunity","volume":"359","author":"Ferrari de Andrade","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.trecan.2025.02.004_bb0280","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","article-title":"Tumor-associated MICA is shed by ADAM proteases","volume":"68","author":"Waldhauer","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.02.004_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.182.1.49","article-title":"Cutting edge: the metalloproteinase ADAM17\/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein","volume":"182","author":"Boutet","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0290","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.4049\/jimmunol.0903789","article-title":"Cutting edge: the membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases","volume":"184","author":"Liu","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0295","doi-asserted-by":"crossref","first-page":"15556","DOI":"10.1038\/s41598-020-72688-y","article-title":"The fatty-acid amide hydrolase inhibitor URB597 inhibits MICA\/B shedding","volume":"10","author":"Sekiba","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.02.004_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.trecan.2025.02.004_bb0305","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/s41467-022-29401-6","article-title":"USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy","volume":"13","author":"Xiong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0310","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","article-title":"USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0315","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41467-023-37617-3","article-title":"Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy","volume":"14","author":"Yi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0320","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0325","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1038\/s41467-024-50996-5","article-title":"Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation","volume":"15","author":"Sun","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0330","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1016\/j.cell.2024.08.007","article-title":"Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity","volume":"187","author":"Fontana","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0335","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2025.02.004_bb0340","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/ph17070951","article-title":"Cancer cell secreted legumain promotes gastric cancer resistance to anti-PD-1 immunotherapy by enhancing macrophage M2 polarization","volume":"17","author":"Pei","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.trecan.2025.02.004_bb0345","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0350","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1189\/jlb.0508285","article-title":"Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X","volume":"84","author":"Obermajer","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0355","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181612","article-title":"YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production","volume":"134","author":"Wen","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1158\/2159-8290.CD-24-0134","article-title":"TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis acting on infiltrating CD8+ T cells","volume":"15","author":"Priego","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.02.004_bb0365","first-page":"485","article-title":"Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors","volume":"4","author":"Cattaruzza","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2025.02.004_bb0370","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"Miguel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.02.004_bb0375","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","article-title":"Bortezomib induces anti\u2013multiple myeloma immune response mediated by cGAS\/STING pathway activation","volume":"2","author":"Gulla","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.trecan.2025.02.004_bb0380","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2016.03.021","article-title":"ARCII: a phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer","volume":"119","author":"Wilson","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0385","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jamaoncol.2019.2095","article-title":"Clinical outcomes of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA\/IIIB non\u2013small cell lung cancer: a phase 1\/2 trial","volume":"5","author":"Rengan","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0390","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2741\/2784","article-title":"Nelfinavir monotherapy increases na\u00efve T-cell numbers in HIV-negative healthy young adults","volume":"13","author":"Rizza","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.trecan.2025.02.004_bb0395","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1073\/pnas.1614035114","article-title":"Gpr132 sensing of lactate mediates tumor\u2013macrophage interplay to promote breast cancer metastasis","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2025.02.004_bb0400","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.cell.2013.10.053","article-title":"Proteolysis inside the membrane is a rate-governed reaction not driven by substrate affinity","volume":"155","author":"Dickey","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0405","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41422-020-00454-w","article-title":"The noncanonical role of the protease cathepsin D as a cofilin phosphatase","volume":"31","author":"Liu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.trecan.2025.02.004_bb0410","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41467-024-45558-8","article-title":"Intercellular transfer of cancer cell invasiveness via endosome-mediated protease shedding","volume":"15","author":"Wenzel","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0415","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc2823","article-title":"The regulatory crosstalk between kinases and proteases in cancer","volume":"10","author":"L\u00f3pez-Ot\u00edn","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.02.004_bb0420","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2017.219","article-title":"Mechanistic enzymology in drug discovery: a fresh perspective","volume":"17","author":"Holdgate","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2025.02.004_bb0425","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-022-04414-9","article-title":"Mechanism-based traps enable protease and hydrolase substrate discovery","volume":"602","author":"Tang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0430","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrm2120","article-title":"In search of partners: linking extracellular proteases to substrates","volume":"8","author":"Overall","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0440","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41418-022-01102-z","article-title":"Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer","volume":"30","author":"Yang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.trecan.2025.02.004_bb0445","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1126\/science.1080106","article-title":"Activation of lysosomal function during dendritic cell maturation","volume":"299","author":"Trombetta","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.trecan.2025.02.004_bb0450","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ccell.2022.08.008","article-title":"High-performance multiplex drug-gated CAR circuits","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0455","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12882-023-03215-0","article-title":"A risk signature of ubiquitin-specific protease family predict the prognosis and therapy of kidney cancer patients","volume":"24","author":"Wang","year":"2023","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0460","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","article-title":"Tumour evolution and microenvironment interactions in 2D and 3D space","volume":"634","author":"Mo","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0465","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0470","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0475","first-page":"1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2025.02.004_bb0480","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1038\/s41467-024-49825-6","article-title":"An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0485","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-024-07443-8","article-title":"Engineered CD47 protects T cells for enhanced antitumour immunity","volume":"630","author":"Yamada-Hunter","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0490","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41590-023-01671-2","article-title":"CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity","volume":"24","author":"Tang","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0495","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178628","article-title":"Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma","volume":"134","author":"Liu","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0500","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ccell.2019.05.003","article-title":"Symbiotic macrophage-glioma cell interactions reveal synthetic lethality in PTEN-null glioma","volume":"35","author":"Chen","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.02.004_bb0505","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2159-8290.CD-19-0400","article-title":"Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment","volume":"10","author":"Chen","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.02.004_bb0510","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147552","article-title":"Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0515","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc1121","article-title":"Molecular mechanisms of glioma invasiveness: the role of proteases","volume":"3","author":"Rao","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.02.004_bb0520","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s12276-024-01163-9","article-title":"Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.trecan.2025.02.004_bb0525","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1172\/JCI77053","article-title":"Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer","volume":"124","author":"Eruslanov","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.02.004_bb0530","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature14407","article-title":"MET is required for the recruitment of anti-tumoural neutrophils","volume":"522","author":"Finisguerra","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0535","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41467-022-28492-5","article-title":"Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications","volume":"13","author":"Xia","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0540","doi-asserted-by":"crossref","first-page":"36865","DOI":"10.1038\/srep36865","article-title":"Cancer derived peptide of vacuolar ATPase \u2018a2\u2019 isoform promotes neutrophil migration by autocrine secretion of IL-8","volume":"6","author":"Ibrahim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.02.004_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-04585-3","article-title":"Tumour cell apoptosis modulates the colorectal cancer immune microenvironment via interleukin-8-dependent neutrophil recruitment","volume":"13","author":"Schimek","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.02.004_bb0550","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","article-title":"CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy","volume":"14","author":"Chang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0555","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.02.004_bb0560","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nri1603","article-title":"A new self: MHC-class-I-independent natural-killer-cell self-tolerance","volume":"5","author":"Kumar","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0565","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/s41467-021-22755-3","article-title":"IFN-\u03b3-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella","volume":"12","author":"Lin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.02.004_bb0570","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2025.02.004_bb0575","doi-asserted-by":"crossref","first-page":"14305","DOI":"10.1038\/s41598-019-50308-8","article-title":"Differential Modulation of Human Innate Lymphoid Cell (ILC) Subsets by IL-10 and TGF-\u03b2","volume":"9","author":"Bonne-Ann\u00e9e","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:54:47Z","timestamp":1778882087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803325000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2405803325000524"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2025.02.004","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease regulation of tumor-immune cell symbiosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}